{"disease":{"id":"vaccine-immune-response","name":"vaccine immune response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03399357","title":"Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Tan Tock Seng Hospital","has_results":false},{"nct_id":"NCT05258708","title":"COVID-19 Vaccine Reactogenicity and Immunogenicity","phase":"","overall_status":"UNKNOWN","enrollment_count":179,"lead_sponsor_name":"Korea University Guro Hospital","has_results":false},{"nct_id":"NCT05315856","title":"Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Korea University Guro Hospital","has_results":false},{"nct_id":"NCT06821100","title":"Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":false},{"nct_id":"NCT05231369","title":"Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"Chulalongkorn University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}